Sort by

Send to

Choose Destination

Search results

Items: 4


Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants.

Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, Sewraj P, van Niekerk N, Jean-Philippe P, Adrian PV; CIPRA-4 team.

Vaccine. 2013 Jan 21;31(5):777-83. doi: 10.1016/j.vaccine.2012.11.076. Epub 2012 Dec 8.


Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.

Madhi SA, Violari A, Klugman KP, Lin G, McIntyre JA, von Gottberg A, Jean-Philippe P, Cotton MF, Adrian P; CIPRA 4 team.

Vaccine. 2011 Sep 16;29(40):6994-7001. doi: 10.1016/j.vaccine.2011.07.035. Epub 2011 Jul 23.


Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants.

Madhi SA, Adrian P, Cotton MF, McIntyre JA, Jean-Philippe P, Meadows S, Nachman S, Käyhty H, Klugman KP, Violari A; Comprehensive International Program of Research on AIDS 4 Study Team.

J Infect Dis. 2010 Aug 15;202(3):355-61. doi: 10.1086/653704.


Early antiretroviral therapy and mortality among HIV-infected infants.

Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA; CHER Study Team.

N Engl J Med. 2008 Nov 20;359(21):2233-44. doi: 10.1056/NEJMoa0800971.

Supplemental Content

Loading ...
Support Center